If we want to increase human fertility, mice have something to tell us: fecal transplants

We knew that the bacteria that live in our intestine They are really positive and offer us extra protection against numerous threats from outside or even against Alzheimer’s. Now they have just added a new star function: they can help us improve our reproductive health. And all this with a simple fecal microbiota transplant. New evidence. This same month of March the magazine Nature has published an article that breaks with several scientific paradigms and demonstrates a bidirectional communication between the microbiome and women’s ovaries. The study here wanted to demonstrate that fecal microbiota transplant can completely remodel the behavior of the ovaries, reducing inflammation and even increasing reproductive success. But the most amazing thing about the experiment is not the ‘what’, but the ‘how’, since it has quite surprised the experimenters that the result has gone against what they expected. How is it possible? To understand this finding, we must first know the concept of ‘strobolome‘ which will give a lot to talk about in the coming years. In a simple way, it is a set of intestinal bacteria that are capable of metabolizing and modulating the level of estrogen, which is one of the main female sex hormones and closely related to reproduction. Until now, we knew that the microbiota played a role in almost every part of our body, ranging from digestion to our own mental health. But they wanted to go further, and in the past it was noted that they had already begun to explore how to transfer faeces from young mice to old ones, which would improve their ovarian reserve. But the best thing is that doing the opposite could accelerate the aging of the ovaries. The new study. Knowing this, this research team designed an experiment in which healthy adult mice were taken and given antibiotics to cleanse their intestinal flora. From here, they underwent a fecal microbiota transplant from mice in the ‘estropausal’ phase, which is like human menopause. What the researchers here were expecting is that if they were introduced to the microbiota of aged rats in reproductive decline, their ovaries would suffer damage. But the truth is that they were wrong. Results. The results here showed that adult females who received the “estropausal” microbiota not only did not worsen, but rather improved ovarian function and an increase in their fertility. Because? By thoroughly analyzing the organism of these ringworms, using sequencing of the genetic material of the ovaries, it was seen that the transplant had caused a massive remodeling of the ovarian transcriptome. That is, the way in which the genes in the ovaries were expressed had completely changed towards a “younger” profile. In addition, the analyzes revealed a drastic drop in the expression of genes linked to inflammation. The explanation that scientists are considering points directly to the strobolome, since it is possible that the microbiota of the stropausal mice, in its attempt to survive the natural drop in hormones of its original host, has developed brutal compensatory mechanisms. By transplanting these “surviving, super-optimized bacteria” into a young environment, they boosted the health of the recipient ovary. The future. Although in this case this effect has been seen in mouse animal modelsthe implications of this study may allow us to continue advancing treatments that can improve human reproductive health. The goal here is to be able to isolate what exactly are the specific microbial candidates or metabolites responsible for this improvement and in the future we could be talking about probiotic treatments or microbiome-based therapies to prolong fertility. Images | Kelly Sikkema CDC In Xataka | Drinking coffee in the morning has very positive consequences for someone unexpected in your body: the microbiota

Years ago, microbiota transplants seemed like something out of science fiction. Today they are already curing diseases

Sometimes extreme situations require extreme measures, at least in the field of medicine and health. Perhaps to many, the idea of microbiota transplants It seems to them that it belongs to this range of extreme measures. Perhaps more so if we refer to this therapy by its first and last name, because we are talking about fecal microbiota transplants. Let’s start at the beginning, explaining what exactly these transplants are. Although its name is quite descriptive. The central idea of ​​this treatment is to take a sample of intestinal microbiota from a healthy person and transfer it to the patient’s intestine. For this, samples of fecal matter are used, feces from the donor that are treated for introduction into the recipient’s gastrointestinal system. The process begins, therefore, by taking a sample (or several) of the donor feces. First of all, it must be verified that these feces do not contain pathogens but that the “good bacteria” of our digestive system predominate in the sample. Once this filter has been passed, the sample is prepared in different ways depending on how it will be administered. One possibility is to dry, freeze and encapsulate part of these samples to administer them. through a pill. However, the most conventional options involve diluting the sample in saline water and then filter it and enter it into our system gastrointestinal, either through a tube introduced through the mouth or nose and that would reach our stomach; either through a colonoscopy, an endoscopy through the colon. Fixing the imbalance And all this, for what? Interestingly, if we are transplanting microbes from one person to another, the reason is to fight against a pathogenic bacteria, called Clostridioides difficile (C. diff). This is a bacteria that normally inhabits our system gastrointestinal without causing major discomfort. But not always. In these cases, C. diff It can take over the inside of our intestine, wreaking havoc on it. C. diff They feed on toxic compounds that they metabolize from some foods we consume and that can end up causing even more damage to our microbiota. This infection It is considered the main cause of diarrhea associated with medical treatments, but this It’s not your only symptom.These include fever, pain or tenderness in the stomach, loss of appetite and nausea, symptoms of gastroenteritis. Some more serious cases They can lead to dehydration, blood or pus in the stool, and kidney failure. One of the problems associated with this bacteria is the appearance of recurrent infections: many patients become ill again between two and eight weeks after the original infection. The potential of this tool is yet to be explored. A recent study, for example, explored the possibility of using this type of intervention to improve sports performance. A luck of “fecal doping” similar in some ways to existing techniques. Sport, and especially elite sport, can affect our microbiome, which in turn can be exploited in favor of the athletes themselves. These transplants have even been proposed in veterinary. Specifically, to help preserve koalas, as we saw in a studio also presented in 2019 in the magazine Animal Microbiome. Over the last few years we have been discovering new links between our gut microbiome and seemingly very distant aspects of our health. Now we even know that there is a connection between our brain and this one. Unfortunately, we still do not understand the causal relationships operating in this connection. In this sense, recently we came across a link between these transplants and autism. a study published in 2019 in the magazine Scientific Reports observed that symptoms linked to autism were reduced among those who had received this type of transplants. In Xataka | 50% of the population is infected with H. pylori. We are finally eradicating it and that has unexpected consequences Image | shameersrk / chriskeller

It is the beginning of a great revolution in transplants

Science has just taken a giant step, although with caution. For the first time in history, a team of surgeons in China has successfully transplanted the lung of a genetically modified pig to a human receiver. Something that demonstrates that this is a completely viable procedure and that opens the door to follow the clinical trial to mark in the future A before and after in transplants. A transplant that was still an experiment. The patient who received this lung was a 39 -year -old man who was in brain deathand therefore I was not going to improve or get worse because of the transplant. All this because it is not yet a technique that has been considered safe, but is in the experimentation phase. In the case of this patient, the organ could be maintained for nine days, demonstrating that the technique is viable. However, the results, published in the prestigious magazine Nature Medicine, They are full of nuances that remind us how complex this field is. A success that adds to others. This milest hearts, kidneys either Hígados of pork The ultimate goal is ambitious and necessary: ​​create an almost unlimited source of organs for thousands of people who die every year in waiting lists. The most difficult organ of all. If transplanting a kidney or pork is already a feat of medicine, doing so with a lung is to enter a new league of complexity. As explained Muhammad Mohiuddin, surgeon from the University of Maryland that led the first pork transplant to a living person, The lungs are really complex having “the largest amount of blood vessels of any transplantable organ.” The fact of being such a vascularized organ makes the receptor’s immune system expose in a very aggressive way, which increases the risk of rejection, but it is also a challenge for coagulation and tissue damage. A great exposure to any allergen. But in addition to being exposed to our adaptive and innate immune system through blood, it must also be taken into account that the lungs are in contact with the outside. This means that with each breath it is exposed to allergens, pollutants, viruses and bacteria, so its immune response is much more aggressive. To get an idea, according to Dr. Leonardo Riella of the Massachusetts General Hospital, a transplanted human kidney can last between 12 and 14 years; A lung, just 5 to 7 years. A pig with human software. To overcome these barriers, the first affiliated hospital team at the Medical University of Guangzhou used the lung of a pig that had been genetically modified. To do this, the organ had six key genetic editions. The first thing they did was eliminate three pigs to reduce the risk that the human immune system would identify it as a threat and trigger immediate rejection. But in addition to eliminating genetic information from the fence, it was also chosen to integrate three human genes into its genome to protect the organ of the immune attack and prevent the formation of clots. A living human being was not put at risk. Surgery was performed on May 15, 2024 in a receiver in brain death, which allowed to study the behavior of the organ without jeopardizing a living patient. During the first three days there were no signs of acute rejection, a first resounding success. However, the problems soon appeared. 24 hours after the intervention the lung began to swell. Damage was also observed due to the lack of oxygen during the transplant procedure, as well as Rejection signs mediated by antibody in the days three later. Interestingly, the team noticed that this damage seemed to have been reduced for the ninth day, at which time studied was arrested at the request of the receiver’s family. The great criticism: a “lost opportunity.” Despite the achievement, the scientific community has indicated an important limitation in the design of the experiment. The surgeons only transplanted the left lung of the pig, leaving the right lung of the receiver, which was human and functional, in place. This, according to some critics such as Dr. Richard N. Pierson of Harvard’s Faculty of Medicine, is a “lost opportunity.” Not insulating the pigs, it is impossible to know if it really worked enough to keep life on its own. A first step in a marathon. Despite criticism and mixed results, experts agree that it is a fundamental advance in being a first step towards clinical pulmonary xenotransplantation. Now the way to follow is to improve the organ preservation techniques to reduce the initial damage and continue to refine the genetic modifications. The next step, according to experts, is to try in the terminal pulmonary patients who have no other treatment option. This experiment is part of a global movement. In the United States, the FDA has already authorized clinical trials for kidney transplants and pigs of companies such as Engenesis and United Therapeutics. In fact, a man lives with A pork kidney since January of this yearmarking the survival record to date. Images | Christopher Carson Weermeijer Robina In Xataka | Make cardio or train strength: for science there is no debate about what is the ideal year from 50

We are one step closer to converting pancreatic islet transplants into a functional therapy against type 1 diabetes

The incidence of Type 1 diabetes It is less than that of its “sister”, but the World Health Organization esteem that more than 64 million people suffer only in Europe. In Spain, the number of cases exceeds 166,000 according to estimates of the National Health System. A new path. A study led by researchers from the University of Leiden has presented a new production method of endocrine cell groupings for transplantation. This tool could help us advance in this type of treatments against type 1 diabetes. Pancreatic islets. The work focuses on the pancreatic islet transplant. These islets are “groupings” of endocrine cells, hormone producing cells. Type 1 diabetes is triggered when our own immune system attacks pancreatic beta cells, insulin producing cells. The problem of transplanting these islets is to obtain them. An option is to obtain them from deceased donors, but this limits their availability. Another option is to “cultivate them” in laboratory from induced pluripotent stem cells. Easier to say than to do. However, there is a problem to solve, and these stem cells can differentiate themselves in the endocrine cells we are looking for, but they can also differentiate in other cells. “This is a problem because if you want to generate a reliable and safe product we need to be very pure, and that it does not vary in composition or purity from one lot to another,” explained to Sinc Adrián Villalba, an immunologist who works precisely in the development of this type of islets. A new method. In the new work, the team raises a new mechanism that facilitates the process of purifying unwanted cells without harming the integrity of the islets to be transplanted. The mechanism is based on density gradient centrifugation, used to enrich endocrine cell clusters and reduce the number of unwanted cells. The team tested their method successfully in mice. They observed that the transplanted islets remained viable for a period of six months. The details of the study were published In an article In the magazine Translational Medicine Science. A future still distant. Animals in animals are a key step, but it remains to be determined to what extent we can replicate the success of these first experiments in human cells. The success achieved so much in alive as In vitrothey point to optimism for now, but there is still time until we can see this progress turned into therapy. The team stands out in your work that this is a “fast” and “scalable method to large volumes of cells.” A method that can also be applied to cellular “manufacturing.” They also indicate the possibility of applying this method to contribute to the creation of new and improved cells based on cells in regenerative medicine, “beyond the field of islets (stem cells).” In Xataka | The 42,000 punctures of Elizabeth Hughes and the miraculous discovery of insulin Image | ISENS USA / Jakob Suckale

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.